Regencell Bioscience Holdings Cash Flow Statement 2019-2024 | RGC

Fifteen years of historical annual cash flow statements for Regencell Bioscience Holdings (RGC).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$-4.36$-6.06$-7.59$-1.35$-0.81$-0.39
$0.31$0.29$0.15$0.03$0.01$0
$0.64$1.32$3.20$0$0$0
$0.95$1.61$3.35$0.03$0.01$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$-0.59$-0.51$-1.02$0.55$0.08$0
$-0.59$-0.51$-1.02$0.55$0.08$0
$-4.00$-4.96$-5.27$-0.77$-0.73$-0.39
$-0.01$-0.03$-0.78$0$-0.12$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$5.25$0.09$-10.00$0$0$0
$0$0$0$0$0$0
$5.25$0.09$-10.00$0$0$0
$0$0$0$0$0$0
$5.24$0.06$-10.78$0$-0.12$0
$0$0$0$0$0$0
$0$0$-0.43$0.61$0.99$0.48
$0$0$-0.43$0.61$0.99$0.48
$0$0$22.67$0$0$0
$0$0$22.67$0$0$0
$0$0$0$0$0$0
$0.10$0.13$0.16$-0.17$0$0
$0.10$0.13$22.41$0.44$0.99$0.48
$1.40$-4.85$6.36$-0.33$0.14$0.09
$0.45$0.92$2.76$0$0$0
$0$0$0$0$0$0